Louis Bisson
Overview
Explore the profile of Louis Bisson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forest-Nault C, Koyuturk I, Gaudreault J, Pelletier A, LAbbe D, Cass B, et al.
Methods Mol Biol
. 2024 Feb;
2762:89-105.
PMID: 38315361
Surface plasmon resonance (SPR)-based biosensing enables the characterization of protein-protein interactions. Several SPR-based approaches have been designed to evaluate the binding mechanism between the angiotensin-converting enzyme 2 (ACE2) receptor and...
2.
Joubert S, Stuible M, Lord-Dufour S, Lamoureux L, Vaillancourt F, Perret S, et al.
Biotechnol Bioeng
. 2023 Mar;
120(7):1746-1761.
PMID: 36987713
Protein expression from stably transfected Chinese hamster ovary (CHO) clones is an established but time-consuming method for manufacturing therapeutic recombinant proteins. The use of faster, alternative approaches, such as non-clonal...
3.
Forest-Nault C, Koyuturk I, Gaudreault J, Pelletier A, LAbbe D, Cass B, et al.
Sci Rep
. 2022 Jul;
12(1):11520.
PMID: 35798770
Several key mutations in the Spike protein receptor binding domain (RBD) have been identified to influence its affinity for the human Angiotensin-Converting Enzyme 2 (ACE2). Here, we perform a comparative...
4.
Mignaqui A, Ferella A, Cass B, Mukankurayija L, LAbbe D, Bisson L, et al.
Front Vet Sci
. 2020 Nov;
7:601.
PMID: 33173790
Inactivated Foot-and-Mouth Disease (FMD) vaccine has proven to be effective in the control of the disease. However, its production has some disadvantages, including the costly biosafety facilities required for the...
5.
LAbbe D, Bisson L, Gervais C, Grazzini E, Durocher Y
Methods Mol Biol
. 2018 Sep;
1850:1-16.
PMID: 30242676
Transient gene expression in human embryo kidney 293 (HEK293) cells is an established approach for the rapid production of large amounts of recombinant proteins (r-proteins). Milligram to gram quantities of...
6.
Agrawal V, Slivac I, Perret S, Bisson L, St-Laurent G, Murad Y, et al.
Methods Mol Biol
. 2012 Aug;
911:287-303.
PMID: 22886259
Camelid single domain antibodies fused to noncamelid Fc regions, also called chimeric heavy chain antibodies (cHCAb), offer great potential as therapeutic and diagnostic candidates due to their relatively small size...
7.
Tom R, Bisson L, Durocher Y
CSH Protoc
. 2011 Mar;
2008:pdb.prot4980.
PMID: 21356796
INTRODUCTIONFast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Such proteins often need to be as pure as possible before any...
8.
Tom R, Bisson L, Durocher Y
CSH Protoc
. 2011 Mar;
2008:pdb.prot4979.
PMID: 21356795
INTRODUCTIONFast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Pure r-proteins are often required in large amounts (hundreds of milligrams to...
9.
Tom R, Bisson L, Durocher Y
CSH Protoc
. 2011 Mar;
2008:pdb.prot4978.
PMID: 21356794
INTRODUCTIONFast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Pure r-proteins are often required in large amounts (hundreds of milligrams to...
10.
Tom R, Bisson L, Durocher Y
CSH Protoc
. 2011 Mar;
2008:pdb.prot4977.
PMID: 21356793
INTRODUCTIONFast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Pure r-proteins are often required in large amounts (hundreds of milligrams to...